MINNEAPOLIS, Dec. 20,
2024 /PRNewswire/ -- Bio-Techne Corporation
(NASDAQ: TECH) today announced that Kim
Kelderman, President and Chief Executive Officer, will
present at the 43rd Annual J.P. Morgan Healthcare
Conference on Tuesday, January 14,
2025, at 10:30 a.m. PST. A
live webcast of the presentation can be accessed via the IR
Calendar page of Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ:
TECH) is a global life sciences company providing innovative tools
and bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With hundreds of
thousands of products in its portfolio, Bio-Techne generated
approximately $1.2 billion in net
sales in fiscal 2024 and has approximately 3,100 employees
worldwide. For more information on Bio-Techne and its brands,
please visit https://www.bio-techne.com or follow the
Company on social media
at: Facebook, LinkedIn, Twitter or YouTube.
Contact: David Clair, Vice
President, Investor Relations & Corporate
Development
david.clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302335119.html
SOURCE Bio-Techne Corporation